Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4. It represents a minor metadata update that does not modify any study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-17T09:11:13.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer was updated to show a new ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3), indicating a minor platform/release change without altering study content.
    Difference
    0.0%
    Check dated 2026-04-25T18:27:54.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:14:34.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    - Revision label updated to v3.5.0; no changes to study details.
    Difference
    0.0%
    Check dated 2026-03-20T19:52:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:58:44.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:32:30.000Z thumbnail image

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.